Issue 11, 2013

An expeditious synthesis of imatinib and analogues utilising flow chemistry methods

Abstract

A flow-based route to imatinib, the API of Gleevec, was developed and the general procedure then used to generate a number of analogues which were screened for biological activity against Abl1. The flow synthesis required minimal manual intervention and was achieved despite the poor solubility of many of the reaction components.

Graphical abstract: An expeditious synthesis of imatinib and analogues utilising flow chemistry methods

Supplementary files

Article information

Article type
Paper
Submitted
15 Oct 2012
Accepted
04 Dec 2012
First published
05 Dec 2012

Org. Biomol. Chem., 2013,11, 1822-1839

An expeditious synthesis of imatinib and analogues utilising flow chemistry methods

M. D. Hopkin, I. R. Baxendale and S. V. Ley, Org. Biomol. Chem., 2013, 11, 1822 DOI: 10.1039/C2OB27002A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements